Getting the study drug at the right time is challenging for any clinical trial, and this is more prominent with the multi-regional clinical trials. To have the IMPs and ancillaries at the clinical trial sites in time, the sponsors need to have the right people, processes, facilities, and technology in place. Generally, the sites require […]

Read More →

Japan is one of the world’s leading markets for cosmetic and personal care products. The Beauty and Personal Care Products Market is estimated to grow at a CAGR of 3.5% for the next five years in Japan. Along with this, Cosmetics shipments within Japan generated a market value of around 2.7 trillion Japanese yen in  […]

Read More →

In the last 15 years, the Japanese nutraceutical industry such as dietary supplements and functional foods grew at an average rate of 15 percent per year. In 2019, Japan’s health-related food market was the third-largest in the world with an estimated value of $13.3 billion. In the last few decades, there is a growing appreciation […]

Read More →

Small and mid-size CROs occupy about 44% of the market share of outsourced development works, approximately. These CROs are gaining interest and becoming the choice for startups, small and mid-sized pharmaceutical and biological companies. While, in the first part of this article series on “Contract Research Organizations For Your Clinical Trials“, the top 10 CROs […]

Read More →

Japan stands as the world’s second-biggest medical device market, after the US. The Japanese medical device market is expected to reach from $54.5 billion in 2018 to $74.7 billion in 2025, growing at a compound annual growth rate (CAGR) of 4.6% according to GlobalData, The rapidly aging Japanese population, an increasing number of patients with […]

Read More →

In a way to support and encourage pharma companies to work upon developing drugs or medical devices in rare disease, several country regulatory agencies are coming up with various benefits such as faster approvals, fee concessions and financial benefits etc. These countries include the US, Europe, Japan, Australia, South Korea and most recently, India. Incentives […]

Read More →

Learning about global regulatory requirements and understanding the pathway for approval can help clinical development teams take their global strategy in the right direction. Sharing expertise from regulatory experts for those who need it. (This article was originally published on LinkedIn). It’s no news that we are now living in an era with a tremendous surge […]

Read More →

Japan is the world’s second-largest single-country pharmaceutical market, accounting for approximately 10 percent of global drug sales and expanding quickly. Top foreign pharmaceutical companies operating in Japan enjoy annual growth rates from 12 to 31 percent, rivaling the expansion observed in emerging markets. This growth spurt has been largely attributed to the Japanese government’s multi-year […]

Read More →